A Delaware federal jury said on Friday that Revance Therapeutics owes AbbVie's Allergan Inc $56 million after finding that ...

A federal jury in Delaware found that Revance's rival product infringed patents for Allergan's market-leading neurotoxin ...

AbbVie and its subsidiary Allergan have had a long run of unchallenged success in the market with cosmetic and therapeutic ...

A federal jury July 18 said Revance Therapeutics' skin medication infringed on patents for anti-wrinkle treatment Botox and owes AbbVie-owned Allergan $56 million.

Tell your doctor if you have received any other botulinum toxin product in the last 4 months; have received injections of botulinum toxin such as Myobloc, Dysport, Xeomin, Jeuveau, Daxxify, or ...

Tell your doctor if you have received any other botulinum toxin product in the last 4 months; have received injections of botulinum toxin such as Myobloc, Dysport, Xeomin, Jeuveau, Daxxify, or ...

She completed her dermatology residency at the University of Illinois at Chicago, followed by a fellowship in cosmetic and laser surgery in Houston, Texas. Highlights Botox and similar ...

A Delaware federal jury said on Friday that Revance Therapeutics owes AbbVie's Allergan Inc $56 million after finding that Revance's anti-wrinkle medication Daxxify infringed patents covering ...

This noninvasive procedure may help you reduce areas of stubborn body fat, but be aware of the risks (including paradoxical adipose hyperplasia). Here’s what experts say you should know.